Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study).
Asghar R, Banajeh S, Egas J, Hibberd P, Iqbal I, Katep-Bwalya M, Kundi Z, Law P, MacLeod W, Maulen-Radovan I, Mino G, Saha S, Sempertegui F, Simon J, Santosham M, Singhi S, Thea DM, Qazi S; Severe Pneumonia Evaluation Antimicrobial Research Study Group. Asghar R, et al. BMJ. 2008 Jan 12;336(7635):80-4. doi: 10.1136/bmj.39421.435949.BE. Epub 2008 Jan 8. BMJ. 2008. PMID: 18182412 Free PMC article. Clinical Trial.
Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2-59 months: a multi-centre, double blind, randomised controlled trial in Pakistan.
Hazir T, Qazi SA, Bin Nisar Y, Maqbool S, Asghar R, Iqbal I, Khalid S, Randhawa S, Aslam S, Riaz S, Abbasi S. Hazir T, et al. Arch Dis Child. 2007 Apr;92(4):291-7. doi: 10.1136/adc.2005.092494. Epub 2006 Mar 17. Arch Dis Child. 2007. PMID: 16547082 Free PMC article. Clinical Trial.
Derivation and validation of a novel risk assessment tool to identify children aged 2-59 months at risk of hospitalised pneumonia-related mortality in 20 countries.
Rees CA, Colbourn T, Hooli S, King C, Lufesi N, McCollum ED, Mwansambo C, Cutland C, Madhi SA, Nunes M, Matthew JL, Addo-Yobo E, Chisaka N, Hassan M, Hibberd PL, Jeena PM, Lozano JM, MacLeod WB, Patel A, Thea DM, Nguyen NTV, Kartasasmita CB, Lucero M, Awasthi S, Bavdekar A, Chou M, Nymadawa P, Pape JW, Paranhos-Baccala G, Picot VS, Rakoto-Andrianarivelo M, Rouzier V, Russomando G, Sylla M, Vanhems P, Wang J, Asghar R, Banajeh S, Iqbal I, Maulen-Radovan I, Mino-Leon G, Saha SK, Santosham M, Singhi S, Basnet S, Strand TA, Bhatnagar S, Wadhwa N, Lodha R, Aneja S, Clara AW, Campbell H, Nair H, Falconer J, Qazi SA, Nisar YB, Neuman MI; World Health Organization PREPARE study group. Rees CA, et al. BMJ Glob Health. 2022 Apr;7(4):e008143. doi: 10.1136/bmjgh-2021-008143. BMJ Glob Health. 2022. PMID: 35428680 Free PMC article.
External validation of the RISC, RISC-Malawi, and PERCH clinical prediction rules to identify risk of death in children hospitalized with pneumonia.
Rees CA, Hooli S, King C, McCollum ED, Colbourn T, Lufesi N, Mwansambo C, Lazzerini M, Madhi SA, Cutland C, Nunes M, Gessner BD, Basnet S, Kartasasmita CB, Mathew JL, Zaman SMAU, Paranhos-Baccala G, Bhatnagar S, Wadhwa N, Lodha R, Aneja S, Santosham M, Picot VS, Sylla M, Awasthi S, Bavdekar A, Pape JW, Rouzier V, Chou M, Rakoto-Andrianarivelo M, Wang J, Nymadawa P, Vanhems P, Russomando G, Asghar R, Banajeh S, Iqbal I, MacLeod W, Maulen-Radovan I, Mino G, Saha S, Singhi S, Thea DM, Clara AW, Campbell H, Nair H, Falconer J, Williams LJ, Horne M, Strand T, Qazi SA, Nisar YB, Neuman MI; World Health Organization PREPARE study group48. Rees CA, et al. J Glob Health. 2021 Oct 9;11:04062. doi: 10.7189/jogh.11.04062. eCollection 2021. J Glob Health. 2021. PMID: 34737862 Free PMC article.
Randomized controlled trial of standard versus double dose cotrimoxazole for childhood pneumonia in Pakistan.
Rasmussen ZA, Bari A, Qazi S, Rehman G, Azam I, Khan S, Aziz F, Rafi S, Roghani MT, Iqbal I, Nagi AG, Hussain W, Bano N, van Latum LJ, Khan M; Pakistan COMET (Cotrimoxazole Multicentre Efficacy) Study Group. Rasmussen ZA, et al. Bull World Health Organ. 2005 Jan;83(1):10-9. Epub 2005 Jan 21. Bull World Health Organ. 2005. PMID: 15682244 Free PMC article. Clinical Trial.